Latest Insider Transactions at Humanigen, Inc (HGEN)
This section provides a real-time view of insider transactions for Humanigen, Inc (HGEN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HUMANIGEN, INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HUMANIGEN, INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 18
2023
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
386,350
-3.18%
|
$0
$0.01 P/Share
|
|
May 20
2022
|
Dale Chappell Chief Scientific Officer |
BUY
Open market or private purchase
|
Indirect |
545,488
+4.47%
|
$1,090,976
$2.23 P/Share
|
|
May 19
2022
|
Dale Chappell Chief Scientific Officer |
BUY
Open market or private purchase
|
Indirect |
323,808
+2.83%
|
$647,616
$2.19 P/Share
|
|
May 18
2022
|
Dale Chappell Chief Scientific Officer |
BUY
Open market or private purchase
|
Indirect |
173,700
+1.59%
|
$173,700
$1.96 P/Share
|
|
Mar 11
2022
|
Dale Chappell Chief Scientific Officer |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+8.62%
|
$3,000,000
$3.0 P/Share
|
|
Mar 09
2022
|
Adrian Kilcoyne Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+29.41%
|
$10,000
$2.78 P/Share
|
|
Mar 08
2022
|
Adrian Kilcoyne Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
7,000
+50.0%
|
$14,000
$2.53 P/Share
|
|
Mar 02
2022
|
Edward P. Jordan Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
12,500
+50.0%
|
$25,000
$2.32 P/Share
|
|
Mar 02
2022
|
Cameron Durrant Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
40,000
+36.36%
|
$80,000
$2.34 P/Share
|
|
Aug 12
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
57,551
-0.55%
|
$978,367
$17.16 P/Share
|
|
Aug 11
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
109,647
-1.03%
|
$1,863,999
$17.07 P/Share
|
|
Jul 29
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
29,394
-0.28%
|
$499,698
$17.03 P/Share
|
|
Jul 28
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
9,692
-0.09%
|
$164,764
$17.04 P/Share
|
|
Jul 23
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
5,584
-0.05%
|
$94,928
$17.04 P/Share
|
|
Jul 22
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
178,005
-1.64%
|
$3,026,085
$17.04 P/Share
|
|
Jul 21
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
132,764
-1.21%
|
$2,256,988
$17.14 P/Share
|
|
Jul 14
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
15,177
-0.14%
|
$258,009
$17.06 P/Share
|
|
Jul 09
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
296,036
-2.63%
|
$5,032,612
$17.37 P/Share
|
|
Jul 08
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
48,010
-0.42%
|
$816,170
$17.17 P/Share
|
|
Jul 02
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
102,848
-0.9%
|
$1,748,416
$17.12 P/Share
|
|
Jul 01
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
140,992
-1.22%
|
$2,396,864
$17.1 P/Share
|
|
Jun 30
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
219,256
-1.86%
|
$3,727,352
$17.28 P/Share
|
|
Jun 25
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
1,000,000
-7.82%
|
$17,000,000
$17.8 P/Share
|
|
Jun 24
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
139,529
-1.08%
|
$2,511,522
$18.37 P/Share
|
|
Jun 23
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
133,126
-1.02%
|
$2,396,268
$18.28 P/Share
|
|
Jun 18
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
402,480
-2.99%
|
$7,244,640
$18.5 P/Share
|
|
Jun 17
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
181,423
-1.33%
|
$3,447,037
$19.17 P/Share
|
|
Jun 16
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
158,486
-1.19%
|
$3,011,234
$19.43 P/Share
|
|
Jun 14
2021
|
Cameron Durrant Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
81,441
-30.73%
|
$1,628,820
$20.78 P/Share
|
|
Jun 08
2021
|
Edward P. Jordan Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
14,700
-100.0%
|
$294,000
$20.08 P/Share
|
|
Jun 08
2021
|
Edward P. Jordan Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,700
+50.0%
|
$132,300
$9.65 P/Share
|
|
Jun 07
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
80,636
-0.84%
|
$1,532,084
$19.08 P/Share
|
|
Jun 04
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
127,084
-1.3%
|
$2,287,512
$18.46 P/Share
|
|
Jun 03
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
191,154
-1.91%
|
$3,440,772
$18.37 P/Share
|
|
Jun 02
2021
|
Dale Chappell Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
76,126
-0.76%
|
$1,446,394
$19.01 P/Share
|
|
Mar 11
2021
|
Nomis Bay Ltd. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
37,912
-0.7%
|
$568,680
$15.49 P/Share
|
|
Mar 11
2021
|
Nomis Bay Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
119,201
-2.17%
|
$1,907,216
$16.02 P/Share
|
|
Mar 10
2021
|
Nomis Bay Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
32,469
-0.59%
|
$519,504
$16.46 P/Share
|
|
Mar 09
2021
|
Nomis Bay Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
83,568
-0.15%
|
$1,420,656
$17.24 P/Share
|
|
Mar 01
2021
|
Cameron Durrant Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
111,441
+50.0%
|
-
|
|
Mar 01
2021
|
Cameron Durrant Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
111,441
-100.0%
|
-
|
|
Mar 01
2021
|
Nomis Bay Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
14,100
-0.25%
|
$253,800
$18.65 P/Share
|
|
Feb 26
2021
|
Nomis Bay Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
30,003
-0.53%
|
$570,057
$19.18 P/Share
|
|
Feb 25
2021
|
Nomis Bay Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,402
-0.04%
|
$45,638
$19.17 P/Share
|
|
Feb 24
2021
|
Nomis Bay Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
25,906
-0.46%
|
$492,214
$19.55 P/Share
|
|
Feb 22
2021
|
Nomis Bay Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
77,314
-1.34%
|
$1,778,222
$23.21 P/Share
|
|
Feb 19
2021
|
Nomis Bay Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
37,300
-0.64%
|
$857,900
$23.5 P/Share
|
|
Feb 18
2021
|
Nomis Bay Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
42,408
-0.73%
|
$890,568
$21.7 P/Share
|
|
Feb 17
2021
|
Nomis Bay Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
9,700
-0.17%
|
$184,300
$19.92 P/Share
|
|
Feb 13
2021
|
Nomis Bay Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
16,423
-0.28%
|
$312,037
$19.68 P/Share
|